These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 11776105

  • 21. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, Thakur V, Hasnain SE, Sarin SK.
    J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
    [Abstract] [Full Text] [Related]

  • 22. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
    Shin YM, Heo J, Kim GH, Kang DH, Song GA, Cho M, Yang US, Kim CM, Park HK, Jang HJ.
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823
    [Abstract] [Full Text] [Related]

  • 23. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
    Wang L, Yan J, Zhang ZH, Wang JB, Du YZ, Li XY, Wang YZ.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
    [Abstract] [Full Text] [Related]

  • 24. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
    Hosseini SY, Sabahi F, Amini-Bavil-Olyaee S, Alavian SM, Merat S.
    J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
    [Abstract] [Full Text] [Related]

  • 25. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine].
    Li Z, Guo YB, Hao W, Lin ZH, Jin HY, Liu DG.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):266-9. PubMed ID: 15340574
    [Abstract] [Full Text] [Related]

  • 26. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.
    Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Takagi K, Kobayashi M, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Jan; 39(1):34-40. PubMed ID: 14767732
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
    Deng H, Lv Y, Fu J.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437
    [Abstract] [Full Text] [Related]

  • 28. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
    Yang DH, Liang WF, Xie YJ, Zhao NF, Fan J.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):232-7. PubMed ID: 14612274
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].
    Deal C, Ajana F, Canva V, Mouton Y, Yazdanpanah Y, Wattré P, Bocket L.
    Ann Biol Clin (Paris); 2002 May; 60(5):581-8. PubMed ID: 12368144
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis.
    Shih YH, Yeh SH, Chen PJ, Chou WP, Wang HY, Liu CJ, Lu SF, Chen DS.
    Antivir Ther; 2008 May; 13(4):469-80. PubMed ID: 18672526
    [Abstract] [Full Text] [Related]

  • 31. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.
    Yao G, Cui Z, Wang B, Yao J, Zeng M.
    Chin Med J (Engl); 2002 Dec; 115(12):1814-8. PubMed ID: 12622930
    [Abstract] [Full Text] [Related]

  • 32. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Suzuki F, Akuta N, Suzuki Y, Sezaki H, Arase Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Satoh J, Watahiki S, Kumada H.
    J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
    [Abstract] [Full Text] [Related]

  • 33. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy.
    Hacker HJ, Zhang W, Tokus M, Bock T, Schröder CH.
    Ann N Y Acad Sci; 2004 Jun; 1022():271-81. PubMed ID: 15251972
    [Abstract] [Full Text] [Related]

  • 34. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006 Jun; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 35. [Determination of the lamivudine-resistant mutants of hepatitis B virus].
    Gervain J, Papp I, Csöndes M, Nemesánszky E, Rácz I, Ribiczey P, Telegdy L, Tornai I, Weisz G.
    Orv Hetil; 2003 Jun 22; 144(25):1251-6. PubMed ID: 12901182
    [Abstract] [Full Text] [Related]

  • 36. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
    Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD.
    Hepatology; 1998 Jun 22; 27(6):1670-7. PubMed ID: 9620341
    [Abstract] [Full Text] [Related]

  • 37. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
    Chen JY, Wang LW, Sun XM, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2005 Aug 22; 4(3):393-7. PubMed ID: 16109523
    [Abstract] [Full Text] [Related]

  • 38. [Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].
    Zhou JL, Wu SP.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 22; 12(8):489-90. PubMed ID: 15329211
    [Abstract] [Full Text] [Related]

  • 39. Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
    van der Eijk AA, Hansen BE, Niesters HG, Janssen HL, van de Ende M, Schalm SW, de Man RA.
    J Viral Hepat; 2005 Jul 22; 12(4):364-72. PubMed ID: 15985006
    [Abstract] [Full Text] [Related]

  • 40. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul 22; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.